What is it about?
Many ophthalmic complications have been reported with the use of these immunosuppressive agents to treat rheumatic diseases. This paper reviews current literature on ophthalmic complications related to immunosuppressive agents and provides a summary of possible ocular side effects from these medications.
Featured Image
Read the Original
This page is a summary of: Ocular side effects of antirheumatic medications: a qualitative review, BMJ Open Ophthalmology, January 2020, BMJ,
DOI: 10.1136/bmjophth-2019-000331.
You can read the full text:
Contributors
The following have contributed to this page